top of page
  • Writer's pictureRN Realty Trader

Stocks: Watchlist - TSLA, SHOP, REGN

Updated: Jul 21, 2020

TSLA - With momentum carried over from last week's Q2 deliveries beat (92,650 delivered vs 83,000 expected), the share price is up even further in Pre-market this morning - fast approaching $1,300 pps.  With the Futures and the overall market up as of this post, watch for Tesla to continue upwards today and potentially this week / until earnings / Battery Day in September. 



SHOP - Shopify has been on a Bull run as a result of the boom in e-commerce activity due to the pandemic.  Shopify allows sellers to create their own online stores to capture customers and repeat business.  This is juxtapose to business owners selling on Amazon and being amongst many 3rd-party sellers.  On Amazon, a buyer could cross-shop amongst other sellers of the same or similar products and potentially lose (repeat) customers.  This is even more the case if Amazon creates an AmazonBasics version of the same product.  If Amazon is one side of the coin to sellers, then Shopify is the other.  Some argue over the sky-high valuation of Shopify.  So the inevitable pull-backs, sell-off's, and profit-taking will likely occur. But judging from Amazon's valuation (although Shopify is no Amazon) with a PE of 138, share price approaching $3,000 pps, and the pandemic lingering, it's hard say how high Shopify could rise.  One also must consider how Shopify will play a role in the post-pandemic retail world.




REGN - Announced in Pre-market today they are entering Phase 3/3 in the clinical trial of their Covid-19 "antibody" serum, REGN-COV2.  The creation and use of antibodies specific to the virus are yet another approach to achieving immunity.  The trial is expected to enroll 2,000 patients in the U.S. to assess its ability to prevent disease in those who have been exposed to the coronavirus.  The same antibody serum is also being tested by the National Institute of Allergy and Infectious Diseases in a separate Phase 2/3 study to assess its efficacy in 2,900 patients being treated in the hospital for the coronavirus.  This study is being done in the U.S., Brazil, Mexico, and Chile.




 

Disclaimer: This post represents my own opinion and is not a substitute for professional investment advice. It does not represent a solicitation to buy or sell any security. Investors should conduct their own due diligence and consult their tax and financial advisors before making any investment.


Disclosure: I currently hold a position in: TSLA, SHOP, REGN, AMZN, with the intention of going Long, Intermediate-Long, Long, and Long, respectively.


I wrote this post myself, and it expresses my own opinions while sometimes quoting others. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.


21 views0 comments

Recent Posts

See All
bottom of page